Bonum Therapeutics, Inc.

CIK 1898714 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Bonum Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Apr 17, 2026D0001898714-26-000001
Nov 29, 2022D0001898714-22-000001
Dec 22, 2021D0001898714-21-000001